Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1996 Mar;223(3):273–279. doi: 10.1097/00000658-199603000-00007

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.

K C Conlon 1, D S Klimstra 1, M F Brennan 1
PMCID: PMC1235115  PMID: 8604907

Abstract

OBJECTIVE: The authors reviewed the clinicopathologic characteristics of patients who underwent resection with curative intent for ductal adenocarcinoma of the pancreas between 1983 and 1989. SUMMARY BACKGROUND DATA: Recent studies have demonstrated a reduction in the morbidity and mortality of pancreatic resection and improvement in the actuarial 5-year survival for patients with resected ductal adenocarcinoma. METHODS: Resection with curative intent was performed on 118 of 684 patients (17%) with pancreatic cancer admitted to the authors' institution. Clinical, demographic, treatment, and pathologic variables were analyzed. The original material for all cases was reviewed; nonductal cancers were excluded. RESULTS: The head of the gland was the predominant tumor site (n = 102), followed by the body (n = 9), and tail (n = 7). Seventy-two percent of the patients underwent pancreaticoduodenectomies, 15% underwent total pancreatectomies, 10% underwent distal pancreatectomies, and 3% underwent distal subtotal pancreatectomies. Operative mortality was 3.4%. Median survival was 14.3 months after resection compared with 4.9 months if patients did not undergo resection (p < 0.0001). Twelve patients survived 5 years after surgery (10.2% overall actual 5-year survival rate). Three of the tumors were well differentiated, five were moderately differentiated, and four were poorly differentiated. Extrapancreatic invasion occurred in nine cases (75%), and perineural invasion was present in ten cases (83%). Five tumors exhibited invasion of duodenum, ampulla of Vater, and/or common bile duct, and an additional tumor invaded the portal vein. Lymph node involvement by carcinoma was noted in five cases (42%). Six patients remain alive without evidence of disease at a median follow-up of 101 months (range, 82-133 months). Five patients died of recurrent or metastatic pancreatic cancer at 60, 61, 62, 64, and 64 months, respectively. One patient died at 84 months of metastatic lung cancer without evidence of recurrent pancreatic disease. CONCLUSIONS: This paper emphasizes the grim prognosis of pancreatic ductal adenocarcinoma. Five-year survival cannot be equated to cure. Although pancreatectomy offers the only chance for long-term survival, it should be considered as the best palliative procedure currently available for the majority of patients. This emphasizes the need for the development of novel and effective adjuvant therapies for this disease.

Full text

PDF
273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumel H., Huguier M., Manderscheid J. C., Fabre J. M., Houry S., Fagot H. Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg. 1994 Jan;81(1):102–107. doi: 10.1002/bjs.1800810138. [DOI] [PubMed] [Google Scholar]
  2. Braasch J. W., Deziel D. J., Rossi R. L., Watkins E., Jr, Winter P. F. Pyloric and gastric preserving pancreatic resection. Experience with 87 patients. Ann Surg. 1986 Oct;204(4):411–418. doi: 10.1097/00000658-198610000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bramhall S. R., Allum W. H., Jones A. G., Allwood A., Cummins C., Neoptolemos J. P. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995 Jan;82(1):111–115. doi: 10.1002/bjs.1800820137. [DOI] [PubMed] [Google Scholar]
  4. Cameron J. L., Crist D. W., Sitzmann J. V., Hruban R. H., Boitnott J. K., Seidler A. J., Coleman J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991 Jan;161(1):120–125. doi: 10.1016/0002-9610(91)90371-j. [DOI] [PubMed] [Google Scholar]
  5. Cameron J. L., Pitt H. A., Yeo C. J., Lillemoe K. D., Kaufman H. S., Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993 May;217(5):430–438. doi: 10.1097/00000658-199305010-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Connolly M. M., Dawson P. J., Michelassi F., Moossa A. R., Lowenstein F. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg. 1987 Sep;206(3):366–373. doi: 10.1097/00000658-198709000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Crile G., Jr The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet. 1970 Jun;130(6):1049–1053. [PubMed] [Google Scholar]
  8. Crist D. W., Sitzmann J. V., Cameron J. L. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg. 1987 Sep;206(3):358–365. doi: 10.1097/00000658-198709000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Crowe J. P., Gordon N. H., Fry D. E., Shuck J. M., Hubay C. A. Breast cancer survival and perioperative blood transfusion. Surgery. 1989 Nov;106(5):836–841. [PubMed] [Google Scholar]
  10. Doerr R. J., Yildiz I., Flint L. M. Pancreaticoduodenectomy. University experience and resident education. Arch Surg. 1990 Apr;125(4):463–465. doi: 10.1001/archsurg.1990.01410160049011. [DOI] [PubMed] [Google Scholar]
  11. Edge S. B., Schmieg R. E., Jr, Rosenlof L. K., Wilhelm M. C. Pancreas cancer resection outcome in American University centers in 1989-1990. Cancer. 1993 Jun 1;71(11):3502–3508. doi: 10.1002/1097-0142(19930601)71:11<3502::aid-cncr2820711107>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  12. Fernández-del Castillo C., Rattner D. W., Warshaw A. L. Standards for pancreatic resection in the 1990s. Arch Surg. 1995 Mar;130(3):295–300. doi: 10.1001/archsurg.1995.01430030065013. [DOI] [PubMed] [Google Scholar]
  13. Geer R. J., Brennan M. F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993 Jan;165(1):68–73. doi: 10.1016/s0002-9610(05)80406-4. [DOI] [PubMed] [Google Scholar]
  14. Gordon T. A., Burleyson G. P., Tielsch J. M., Cameron J. L. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg. 1995 Jan;221(1):43–49. doi: 10.1097/00000658-199501000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grace P. A., Pitt H. A., Tompkins R. K., DenBesten L., Longmire W. P., Jr Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg. 1986 Jan;151(1):141–149. doi: 10.1016/0002-9610(86)90024-3. [DOI] [PubMed] [Google Scholar]
  16. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer. 1987 Nov 1;60(9):2284–2303. doi: 10.1002/1097-0142(19871101)60:9<2284::aid-cncr2820600930>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  17. Harris G. J., Gaskill H. V., 3rd, Cruz A. B., Jr Carcinoma of the pancreas: a retrospective review. J Surg Oncol. 1990 Nov;45(3):184–189. doi: 10.1002/jso.2930450311. [DOI] [PubMed] [Google Scholar]
  18. Lea M. S., Stahlgren L. H. Is resection appropriate for adenocarcinoma of the pancreas? A cost-benefit analysis. Am J Surg. 1987 Dec;154(6):651–654. doi: 10.1016/0002-9610(87)90236-4. [DOI] [PubMed] [Google Scholar]
  19. Manabe T., Ohshio G., Baba N., Miyashita T., Asano N., Tamura K., Yamaki K., Nonaka A., Tobe T. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer. 1989 Sep 1;64(5):1132–1137. doi: 10.1002/1097-0142(19890901)64:5<1132::aid-cncr2820640528>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  20. Miedema B. W., Sarr M. G., van Heerden J. A., Nagorney D. M., McIlrath D. C., Ilstrup D. Complications following pancreaticoduodenectomy. Current management. Arch Surg. 1992 Aug;127(8):945–950. doi: 10.1001/archsurg.1992.01420080079012. [DOI] [PubMed] [Google Scholar]
  21. Nitecki S. S., Sarr M. G., Colby T. V., van Heerden J. A. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg. 1995 Jan;221(1):59–66. doi: 10.1097/00000658-199501000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shapiro T. M. Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs Whipple resection in good risk patients. Ann Surg. 1975 Dec;182(6):715–721. doi: 10.1097/00000658-197512000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. St Laurent M., Frazee R. C. Radical pancreatic resection for benign and malignant disease. Am Surg. 1993 Feb;59(2):69–73. [PubMed] [Google Scholar]
  24. Swope T. J., Wade T. P., Neuberger T. J., Virgo K. S., Johnson F. E. A reappraisal of total pancreatectomy for pancreatic cancer: results from U.S. Veterans Affairs hospitals, 1987-1991. Am J Surg. 1994 Dec;168(6):582–586. doi: 10.1016/s0002-9610(05)80126-6. [DOI] [PubMed] [Google Scholar]
  25. Tartter P. I. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg. 1992 Dec;216(6):633–638. doi: 10.1097/00000658-199212000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Trede M., Schwall G., Saeger H. D. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg. 1990 Apr;211(4):447–458. doi: 10.1097/00000658-199004000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wade T. P., el-Ghazzawy A. G., Virgo K. S., Johnson F. E. The Whipple resection for cancer in U.S. Department of Veterans Affairs Hospitals. Ann Surg. 1995 Mar;221(3):241–248. doi: 10.1097/00000658-199503000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Warshaw A. L. Pancreatic surgery. A paradigm for progress in the age of the bottom line. Arch Surg. 1995 Mar;130(3):240–246. doi: 10.1001/archsurg.1995.01430030010001. [DOI] [PubMed] [Google Scholar]
  29. Willett C. G., Lewandrowski K., Warshaw A. L., Efird J., Compton C. C. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg. 1993 Feb;217(2):144–148. doi: 10.1097/00000658-199302000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wingo P. A., Tong T., Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995 Jan-Feb;45(1):8–30. doi: 10.3322/canjclin.45.1.8. [DOI] [PubMed] [Google Scholar]
  31. Wu H. S., Little A. G. Perioperative blood transfusions and cancer recurrence. J Clin Oncol. 1988 Aug;6(8):1348–1354. doi: 10.1200/JCO.1988.6.8.1348. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES